Replies to post #14646 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

So what's ur point about the Ph2b ~ THREE?

You do know the DSMB is not the FDA - right?

What happens at Ph2B impacts whether or not a Ph3 makes sense.

That's including odds of success and whether or not it makes good financial sense - feasible.

Let me know who all is on the DSMB who gave AP the Green Light.

If Anthony Fauci's name pops up I'd say ur onto something.

Otherwise, without a partner for the covid trial it's just more dilution to run a trial that has not reported any statistical significance to date.

So if the truial is unsuccessful there will be posters saying we knew the risks going in.

As if you didn't already know the odds were stacked against you.

In real BioWorld that's usually a deal breaker.

However, this remains pennyland where facts don't matter much at all.

It's a big reason why management gets away with it's mounting BS.

M$